MyFinsight
Home
Blog
About
Proceeds from issuance of
notes payable, net
$7,000K
(0.00%↑ Y/Y)
Proceeds from issuance of
convertible notes payable,...
$925K
(-83.20%↓ Y/Y)
something is missing
$666K
Proceeds from issuance of
common shares
$104K
(-99.16%↓ Y/Y)
Proceeds from exercise of
warrants
$14K
(-39.13%↓ Y/Y)
Proceeds from warrant
modification
$2K
Net cash provided by
financing activities
$7,372K
(-69.51%↓ Y/Y)
Canceled cashflow
$1,339K
Net (decrease)
increase in cash and cash...
-$1,191K
(-155.63%↓ Y/Y)
Canceled cashflow
$7,372K
Accounts payable and
accrued expenses
$2,722K
(-63.87%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,430K
(-2089.19%↓ Y/Y)
Payment to related party
$1,339K
Net cash used in
operating activities
-$7,169K
(55.49%↑ Y/Y)
Canceled cashflow
$5,152K
Effect of exchange rate
changes on cash and cash...
-$1,196K
(78.40%↑ Y/Y)
Net cash used in
investing activities
-$198K
(50.13%↑ Y/Y)
Loss from
extinguishment of debt
-$2,180K
(81.52%↑ Y/Y)
Depreciation and
amortization
$774K
(-12.54%↓ Y/Y)
Stock-based compensation
for services
$181K
(-75.83%↓ Y/Y)
Non - cash financing
cost
-$150K
Amortization of debt discount
$125K
(-85.45%↓ Y/Y)
Amortization of operating
lease right-of-use...
$78K
(-40.00%↓ Y/Y)
Allowance for credit loss
$14K
Net loss
-$9,221K
(73.44%↑ Y/Y)
Subtotal of non-cash
charges
-$2,994K
(-140.66%↓ Y/Y)
Lease liabilities
-$106K
(-371.79%↓ Y/Y)
Purchase of equipment and
construction in progress
$198K
(-50.13%↓ Y/Y)
Canceled cashflow
$3,502K
Change in fair value of
convertible notes
$6,432K
(5.63%↑ Y/Y)
Change in fair value of
share payable
$64K
(124.33%↑ Y/Y)
Back
Back
Cash Flow
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
source: myfinsight.com